104 related articles for article (PubMed ID: 2894428)
1. Muscarinic receptor density is reduced in diabetic rat atria, an effect prevented by the aldose reductase inhibitor, Statil.
Kofo-Abayomi A; Lucas PD
J Pharm Pharmacol; 1987 Dec; 39(12):1019-21. PubMed ID: 2894428
[TBL] [Abstract][Full Text] [Related]
2. Axonal transport and tissue contents of substance P in rats with long-term streptozotocin-diabetes. Effects of the aldose reductase inhibitor 'statil'.
Robinson JP; Willars GB; Tomlinson DR; Keen P
Brain Res; 1987 Nov; 426(2):339-48. PubMed ID: 2446712
[TBL] [Abstract][Full Text] [Related]
3. Studies on peripheral nerve and lens in long-term experimental diabetes: effects of the aldose reductase inhibitor statil.
Willars GB; Townsend J; Tomlinson DR; Compton AM; Churchill RD
Metabolism; 1988 May; 37(5):442-9. PubMed ID: 2452959
[TBL] [Abstract][Full Text] [Related]
4. Reduced anterograde and retrograde accumulation of axonally transported phosphofructokinase in streptozotocin-diabetic rats: effects of insulin and the aldose reductase inhibitor 'Statil'.
Willars GB; Calcutt NA; Tomlinson DR
Diabetologia; 1987 Apr; 30(4):239-43. PubMed ID: 2439402
[TBL] [Abstract][Full Text] [Related]
5. Treatment with an aldose reductase inhibitor can reduce the susceptibility of fast axonal transport following nerve compression in the streptozotocin-diabetic rat.
Dahlin LB; Archer DR; McLean WG
Diabetologia; 1987 Jun; 30(6):414-8. PubMed ID: 2445613
[TBL] [Abstract][Full Text] [Related]
6. The effect of aldose reductase inhibitor, statil, on hyperpermeability of iridial vessels in experimental galactosemic rats.
Terubayashi H; Akagi Y
Jpn J Ophthalmol; 1989; 33(3):343-7. PubMed ID: 2507812
[TBL] [Abstract][Full Text] [Related]
7. Sorbitol metabolism in the retina, optic nerve, and sural nerve of diabetic rats treated with an aldose reductase inhibitor.
Naeser P; Brolin SE; Eriksson UJ
Metabolism; 1988 Dec; 37(12):1143-5. PubMed ID: 3143049
[TBL] [Abstract][Full Text] [Related]
8. Aldose reductase inhibition and glomerular abnormalities in diabetic rats.
Daniels BS; Hostetter TH
Diabetes; 1989 Aug; 38(8):981-6. PubMed ID: 2502460
[TBL] [Abstract][Full Text] [Related]
9. Fast anterograde axonal transport in wasted and non-wasted diabetic rats; effects of aldose reductase inhibition.
Whiteley SJ; Townsend J; Tomlinson DR; Willars GB
Diabetes Res; 1986 Nov; 3(9):447-52. PubMed ID: 2435444
[TBL] [Abstract][Full Text] [Related]
10. Statil-sensitive polyol formation in nerve of galactose-fed mice.
Calcutt NA; Willars GB; Tomlinson DR
Metabolism; 1988 May; 37(5):450-3. PubMed ID: 3130544
[TBL] [Abstract][Full Text] [Related]
11. Slow component-a of axonal transport, nerve myo-inositol, and aldose reductase inhibition in streptozocin-diabetic rats.
Tomlinson DR; Sidenius P; Larsen JR
Diabetes; 1986 Apr; 35(4):398-402. PubMed ID: 2420664
[TBL] [Abstract][Full Text] [Related]
12. No influence of an aldose reductase inhibitor on glycogen deposition in tubules from streptozotocin diabetic rats.
Rasch R; Osterby R
J Diabet Complications; 1989; 3(4):198-201. PubMed ID: 2533211
[TBL] [Abstract][Full Text] [Related]
13. Properties of ICI 128,436, a novel aldose reductase inhibitor, and its effects on diabetic complications in the rat.
Stribling D; Mirrlees DJ; Harrison HE; Earl DC
Metabolism; 1985 Apr; 34(4):336-44. PubMed ID: 3920474
[TBL] [Abstract][Full Text] [Related]
14. Increased steady-state levels of laminin B1 mRNA in kidneys of long-term streptozotocin-diabetic rats. No effect of an aldose reductase inhibitor.
Poulsom R; Kurkinen M; Prockop DJ; Boot-Handford RP
J Biol Chem; 1988 Jul; 263(21):10072-6. PubMed ID: 2839472
[TBL] [Abstract][Full Text] [Related]
15. Prevention of defective axonal transport in streptozocin-diabetic rats by treatment with "Statil" (ICI 128436), an aldose reductase inhibitor.
Tomlinson DR; Townsend J; Fretten P
Diabetes; 1985 Oct; 34(10):970-2. PubMed ID: 2412918
[TBL] [Abstract][Full Text] [Related]
16. [Prevention of experimental diabetic corneal endotheliopathy with a new aldose reductase inhibitor].
Terubayashi H; Akagi Y; Takahashi Y; Ikebe H; Miyamoto Y; Ibaraki N; Yokoi N; Tutumi M; Itoi M
Nippon Ganka Gakkai Zasshi; 1988 Jan; 92(1):151-5. PubMed ID: 3133928
[No Abstract] [Full Text] [Related]
17. Antioxidant status in an in vitro model for hyperglycemic lens cataract formation: effect of aldose reductase inhibitor statil.
Hothersall JS; Taylaur CE; McLean P
Biochem Med Metab Biol; 1988 Oct; 40(2):109-17. PubMed ID: 3142503
[TBL] [Abstract][Full Text] [Related]
18. The effect of aldose reductase inhibitor Statil (ICI 128436) on the glucose over-utilization in kidney of diabetic rats.
Sochor M; Kunjara S; McLean P
Biochem Pharmacol; 1988 Sep; 37(17):3349-56. PubMed ID: 2969732
[TBL] [Abstract][Full Text] [Related]
19. Effect of aldose reductase inhibition on nerve conduction velocity and resistance to ischemic conduction block in experimental diabetes.
Price DE; Airey CM; Alani SM; Wales JK
Diabetes; 1988 Jul; 37(7):969-73. PubMed ID: 3133261
[TBL] [Abstract][Full Text] [Related]
20. Contractile properties of cardiac papillary muscle in streptozotocin-diabetic rats and the effects of aldose reductase inhibition.
Cameron NE; Cotter MA; Robertson S
Diabetologia; 1989 Jun; 32(6):365-70. PubMed ID: 2503412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
